UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

The lancet oncology, 2015-07, Vol.16 (7), p.839-847

2015

Volltextzugriff (PDF)

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

Haematologica (Roma), 2018-08, Vol.103 (8), p.e368

2018

Volltextzugriff (PDF)

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

European journal of cancer (1990), 2019-01, Vol.107, p.37-45

2019

Volltextzugriff (PDF)

AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel

Molecular oncology, 2019-08, Vol.13 (8), p.1795-1807

2019

Volltextzugriff (PDF)

Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer

BMC cancer, 2019-02, Vol.19 (1), p.160-160, Article 160

2019

Volltextzugriff (PDF)

Effects of Budesonide on Cabazitaxel Pharmacokinetics and Cabazitaxel-Induced Diarrhea: A Randomized, Open-Label Multicenter Phase II Study

Clinical cancer research, 2017-04, Vol.23 (7), p.1679-1683

2017

Volltextzugriff (PDF)

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Blood cancer journal (New York), 2022-09, Vol.12 (9), p.125-125, Article 125

2022

Volltextzugriff (PDF)

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

Cancers, 2019-08, Vol.11 (8), p.1212

2019

Volltextzugriff (PDF)

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy

Cancer reports, 2022-02, Vol.5 (2), p.e1470-n/a

2022

Volltextzugriff (PDF)

Optimal treatment of opioid induced constipation in daily clinical practice - an observational study

BMC palliative care, 2019-03, Vol.18 (1), p.31-31, Article 31

2019

Volltextzugriff (PDF)

Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice

Frontiers in pharmacology, 2016-09, Vol.7, p.310-310

2016

Volltextzugriff (PDF)

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

The lancet oncology, 2018-05, Vol.19 (5), p.616-628

2018

Volltextzugriff (PDF)

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

The lancet oncology, 2019-02, Vol.20 (2), p.216-228

2019

Volltextzugriff (PDF)

AIPAC-003: A randomized, double-blind, placebo-controlled phase 3 trial testing eftilagimod alpha (soluble LAG-3) in patients with HER2-neg/low metastatic breast cancer receiving paclitaxel, following an open-label dose optimization

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS1120-TPS1120

2023

Volltextzugriff (PDF)

Retroperitoneal mature teratoma after orchidectomy for a stage IB pure embryonal testicular carcinoma

International journal of clinical oncology, 2008-02, Vol.13 (1), p.71-73

2008

Volltextzugriff (PDF)

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

Journal of clinical oncology, 2020-10, Vol.38 (29), p.3377-3387

2020

Volltextzugriff (PDF)

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.3529-3531

2022

Volltextzugriff (PDF)

Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity

Supportive care in cancer, 2024-09, Vol.32 (9), p.579, Article 579

2024

Volltextzugriff (PDF)

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

BMC cancer, 2020-08, Vol.20 (1), p.790-10, Article 790

2020

Volltextzugriff (PDF)

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study

Neuro-oncology (Charlottesville, Va.), 2024-04, Vol.26 (4), p.724-734

2024

Volltextzugriff (PDF)

First results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5059-5059

2021

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Oncology
(25)
Humans
(23)
Male
(19)
Aged
(17)
Middle Aged
(16)
Patients
(16)
Adult
(15)
Female
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Chemotherapy
(11)
Aged, 80 And Over
(10)
Hematology
(10)
Metastasis
(9)
Treatment Outcome
(9)
Cancer Therapies
(8)
Survival
(8)
Castration
(7)
Disease-Free Survival
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel

Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer

Effects of Budesonide on Cabazitaxel Pharmacokinetics and Cabazitaxel-Induced Diarrhea: A Randomized, Open-Label Multicenter Phase II Study

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy

P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB‐VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL

Optimal treatment of opioid induced constipation in daily clinical practice - an observational study

Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

AIPAC-003: A randomized, double-blind, placebo-controlled phase 3 trial testing eftilagimod alpha (soluble LAG-3) in patients with HER2-neg/low metastatic breast cancer receiving paclitaxel, following an open-label dose optimization

Retroperitoneal mature teratoma after orchidectomy for a stage IB pure embryonal testicular carcinoma

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC)

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity

Exploratory Results of PET-CT and Residual Lymph Node Fine Needle Aspiration of Patients Treated with First-Line Venetoclax and Ibrutinib for CLL/Sll; First Interim Analysis of the Phase 2 HOVON 158/Next STEP Trial

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study

First results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC)

Suchergebnisse filtern